ArticleiScience2026
Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Broadly HIV-neutralizing antibodies (bnAbs) targeting viral envelope (Env) antigens are promising for HIV/AIDS treatment, functional cure, and prevention. However, individual bnAb epitope classes show distinct gaps in coverage of Env diversity, supporting the use of antibody combinations to improve breadth and potency. We examined how frequently multiple bnAb classes bind simultaneously to individual virions using quantitative single-particle fluorescence correlation spectroscopy (FCS) and FRET approaches. These methods quantified unmodified virion subpopulations from multiple strains bound by one or more fluorescently labeled bnAbs. Analysis of N49P7, PGT121, and PGDM1400, targeting the CD4-binding site, V3-glycan region, and trimer apex, respectively, revealed subpopulations bound by one, two, or three bnAbs. Across strains, the proportion of virions bound by all three antibodies correlated significantly with neutralization activity. These findings define the distribution of combinatorial bnAb binding across heterogeneous virion populations and support quantitative single-particle fluorescence approaches for evaluating antibody combinations against HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.